deltatrials
Unknown OBSERVATIONAL NCT04562077

Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome

Sponsor: Assiut University

Conditions Glioma, Malignant Recurrent Glioma
Updated 6 times since 2020 Last updated: Sep 18, 2020 Started: Oct 31, 2020 Primary completion: Nov 30, 2021 Completion: Nov 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Glioma, Malignant and Recurrent Glioma, this trial is ongoing. The trial is conducted by Assiut University and has accumulated 6 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Oct 2022 · 21 months · monthly snapshotNot Yet Recruiting~Oct 2022 – ~Jul 2024 · 21 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  4. Oct 2022 — Jul 2024 [monthly]

    Unknown Status

    Status: Not Yet Recruiting → Unknown Status

  5. Jan 2021 — Oct 2022 [monthly]

    Not Yet Recruiting

▶ Show 1 earlier version

  1. Oct 2020 — Jan 2021 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Assiut University
Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations